Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 12, 2014, Pages

  Day, Julia ^a   Zienius, Karolis ^a   Gehring, Karin ^b   Grosshans, David ^c   Taphoorn, Martin ^d   Grant, Robin ^a   Li, Jing ^c   Brown, Paul D ^c  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b TILBURG UNIVERSITY   (Netherlands)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMETHYLPHENIDATE; MEMANTINE; METHYLPHENIDATE; MODAFINIL; BENZHYDRYL DERIVATIVE; DONEPEZIL; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE; CENTRAL STIMULANT AGENT; NEUROPROTECTIVE AGENT; OXYGEN;

ADULT; ANGER; ANXIETY; BRAIN METASTASIS; COGNITION; COGNITIVE BEHAVIORAL THERAPY; COGNITIVE DEFECT; COGNITIVE REHABILITATION; CONFUSION; DAILY LIFE ACTIVITY; DEPRESSION; DIETARY SUPPLEMENT; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FUNCTIONAL STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MEMORY; MENTAL PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SELF REPORT; SIDE EFFECT; SKULL IRRADIATION; SLEEP DISORDER; SYSTEMATIC REVIEW; TIME TO TREATMENT; TREATMENT OUTCOME; WELLBEING; COGNITION DISORDERS; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); ARTICLE; EXERCISE; HYPERBARIC OXYGEN THERAPY; PRIMARY PREVENTION;

ADULT; BENZHYDRYL COMPOUNDS; COGNITION DISORDERS; CRANIAL IRRADIATION; HUMANS; INDANS; MEMANTINE; METHYLPHENIDATE; NOOTROPIC AGENTS; PIPERIDINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84925226698     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011335.pub2     Document Type: Review

References (88)

1. Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-Oncology 2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]
2. Butler JM Jr, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics 2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]
3. Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-Oncology 2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]
4. Kaleita TA, Wellisch DK, Graham CA, Steh B, Nghiemphu, Ford JM, et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. Journal of Clinical Oncology. 2006; Vol. 24, issue 18S:1503.
5. Locke DEC, Cerhan JH, Wu W, Malec JF, Clark MM, Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology 2008;6(8):383-91.
6. Rapp SR, Case D, Peiffer A, Naughton MJ, Stieber VW, Bayer GK, et al. Phase III randomized, double-blind, placebo-controlled trial of donepezil in irradiated brain tumor survivors. Journal of Clinical Oncology. 2013; Vol. 31:2006.
7. Attia A, Rapp SR, Case LD, D'Agostino R, Lesser G, Naughton M, et al. Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood. Journal of Neuro-Oncology 2012;109:357-63. [DOI: 10.1007/s11060-012-0901-9]
8. Boele FW, Douw L, de Groot M, Van Thuijl HF, Cleijne W, Heimans JJ, et al. The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial. Neuro-Oncology 2013;15(10):1420-8. [DOI: 10.1093/neuonc/not102]
9. Chan AS, Cheung MC, Law SC, Chan JH. Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer 2004;100(2):398-404. [DOI: 10.1002/cncr.11885]
10. Gehring K, Sitskoorn MM, Gundy CM, Sikkes SAM, Klein M, Postma TJ, et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. Journal of Clinical Oncology 2009;27(22):3712-22. [DOI: 10.1200/JCO.2008.20.5765]
11. Hulshof MCCM, Stark NM, van der Kleij A, Sminia P, Smeding HMM, Gonzalez DG. Hyperbaric oxygen therapy for cognitive disorders after irradiation of the brain [Hyperbare oxygenierung bei patienten mit kognitiven störungen nach hirnbestrahlung]. Strahlentherapie und Onkologie 2002;178(4):192-8. [DOI: 10.1007/s00066-002-0916-9]
12. Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, Sloan J, et al. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Supportive Care in Cancer 2005;13:66-9. [DOI: 10.1007/s00520-004-0696-0]
13. Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. International Journal of Radiation Oncology *Biology *Physics 2011;79(5):1487-95. [DOI: 10.1016/j.ijrobp.2009.12.061]
14. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood and function of brain tumor patients. Journal of Clinical Oncology 1998;16(7):2522-7.
15. Schellart NAM, Reits D, van der Kleij, Stalpers LJA. Hyperbaric oxygen treatment improved neurophysiologic performance in brain tumor patients after neurosurgery and radiotherapy: a preliminary report. Cancer 2011;117(15):3434-44. [DOI: 10.1002/cncr.25874]
16. Shaw EG, Rosdhal R, D'Agostino RB Jr, Lovato J, Naughton MJ, Robbins ME, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. Journal of Clinical Oncology 2006;24(9):1415-20.
17. Shaw EG, Case D, Bryant D, Grisell D, Lesser G, Monitto DC, et al. Phase II double-blind placebo-controlled study of armodafinil for brain radiation induced fatigue. Journal of Clinical Oncology. 2013; Vol. 13:9505.
18. Umphrey ABP. Armodafinil in reducing cancer-related fatigue in patients with high grade glioma. ClinicalTrials.gov 2013; Vol. NCT01781468.
19. Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. Journal of Clinical Oncology 1998;16(3):859-63.
20. Anscher MS, Swift PS, Gaspar LE, Marks LB. Radiation injury of the brain and spinal cord. In: Wilkins RH, Rengachary SS editor(s). Neurosurgery. New York: McGraw-Hill, 1996:1921-36.
21. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test-revised: normative data and analysis of inter-form and test-retest reliability. Clinical Neuropsychologist 1998;12(1):43-55.
22. Benton AL, Hamsher KS. Multilingual Aphasia Examination. Iowa City, IA, AJA Associates 1989.
23. Challman TD, Lipsky JJ. Methylphenidate: its pharmacology and uses. Mayo Clinic Proceedings 2000;75(7):711-21.
24. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. The Lancet Oncology 2009;10(11):1037-44. [DOI: 10.1016/S1470-2045(09)70263-3]
25. Cicerone KD, Langenbahn DM, Braden C, Malec JF, Kalmar K, Fraas M, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Archives of Physical Medicine and Rehabilitation 2011;92(4):519-30.
26. Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ: British Medical Journal 2013;346:1-13.
27. Cochran DC, Chan MD, Aklilu M, Lovato JF, Alphonse NK, Bourland JD, et al. The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. Journal of Neurosurgery 2012;116(5):978-83. [DOI: 10.3171/2012.2.JNS111353]
28. Correa DD, DeAngelis LM, Shi W, Thaler H, Glass A, Abrey LE. Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 2004;62(4):548-55. [PUBMED: 14981169]
29. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. Journal of Clinical Oncology 1994;12(3):627-42.
30. Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M. What do cancer patients mean when they complain of concentration and memory problems?. British Journal of Cancer 1996;74(10):1674-9.
31. David J, Ahlberg FM, Berk M, Ashley DM, Khasraw M. Emerging pharmacotherapy for cancer patients with cognitive dysfunction. BMC Neurology 2013;13(1):153.
32. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39(6):789. [DOI: 10.1212/WNL.39.6.789]
33. Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001;323(7305):157-62. [DOI: 10.1136/bmj.323.7305.157]
34. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
35. Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. The Oncologist 2008;13(12):1285-95. [DOI: 10.1634/thoncologist.2008-0130]
36. Fink J, Born D, Chamberlain MC. Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumors. Current Neurology and Neuroscience Reports 2012;12(3):276-85. [DOI: 10.1007/s11910-012-0258-7]
37. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12(3):189-98.
38. Gehring K, Sitskoorn MM, Aaronson NK, Taphoorn MJB. Interventions for cognitive deficits in adults with brain tumours. The Lancet Neurology 2008;7(6):548-60.
39. Gehring K, Aaronson NK, Taphoorn MJ, Sitskoorn MM. Interventions for cognitive deficits in patients with a brain tumor: an update. Expert Review of Anticancer Therapy 2010;10(11):1779-95.
40. Gehring K, Aaronson NK, Gundy CM, Taphoorn MJB, Sitskoorn MM. Predictors of neuropsychological improvement following cognitive rehabilitation in patients with gliomas. Journal of International Neuropsychological Society 2011;17(2):256-66.
41. Gehring K, Roukema JA, Sitskoorn MM. Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Review of Anticancer Therapy 2012;12(2):255-69. [DOI: 10.1586/era.11.202]
42. Gill AL, Bell CNA. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM: An International Journal of Medicine 2004;97(7):385-95. [DOI: 10.1093/qjmed/hch074]
43. Gilroy J. Basic Neurology. 3rd Edition. New York: McGraw-Hill Health Professions Division, 2000.
44. Gligoroska JP, Manchevska S. The effect of physical activity on cognition - physiological mechanisms. Materia Socio Medica 2012;24(3):198-202. [PUBMED: PMC363396]
45. Gondi V, Paulus R, Bruner DW, Meyers CA, Gore EM, Wolfson A, et al. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of radiation therapy oncology group randomized trials 0212 and 0214. International Journal of Radiation Oncology* Biology* Physics 2013;86(4):656-64. [DOI: 10.1016/j.ijrobp.2013.02.033]
46. Gonzales J, Kumar AJ, Conrad CA, Levin VA. Effect of bevacizumab on radiation necrosis of the brain. International Journal of Radiation Oncology* Biology* Physics 2007;67(2):323-6. [DOI: 10.1016/j.ijrobp.2006.10.010]
47. Greene-Schloesser D, Moore E, Robbins ME. Molecular pathways: radiation-induced cognitive impairment. Clinical Cancer Research 2013;19(9):2294-300.
48. Hassler MR, Elandt K, Preusser M, Lehrner J, Binder P, Dieckmann K, et al. Neurocognitive training in patients with high-grade glioma: a pilot study. Journal of Neuro-Oncology 2010;97(1):109-15.
49. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
50. Khasraw M, Ashley D, Wheeler G, Berk M. Using lithium as a neuroprotective agent in patients with cancer. BMC Medicine 2012;10(1):131.
51. Klein M, Heimans JJ, van der Ploeg HM, Grit J, Muller M, Postma TJ, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002;360(9343):1361-8.
52. Lee AWM, Kwong DLW, Leung SF, Tung SY, Sze WM, Sham JST, et al. Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. International Journal of Radiation Oncology* Biology* Physics 2002;53(1):75-85. [DOI: 10.1016/S0360-3016(02)02711-6]
53. Lidstone V, Butters E, Seed PT, Sinnott C, Beynon T, Richards M. Symptoms and concerns amongst cancer outpatients: identifying the need for specialist palliative care. Palliative Medicine 2003;17(7):588-95.
54. Lyubimova N, Hopewell JW. Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury. British Journal of Radiology 2004;77(918):488-92. [PUBMED: 15151969]
55. Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, Cereser V, Vargas RDS, et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neuroscience Letters 2007;421(1):33-6.
56. Malec JF, Kragness M, Evans RW, Finlay KL, Kent A, Lezak M. Further psychometric evaluation and revision of the Mayo-Portland Adaptability Inventory in a national sample. Journal of Head Trauma Rehabilitation 2003;18(6):479-92.
57. Meyers CA, Hess KR, Yung WA, Levin VA. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. Journal of Clinical Oncology 2000;18(3):646.
58. Meyers CA, Wefel JS. The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. Journal of Clinical Oncology 2003;21(19):3557-8.
59. Miotto EC, Savage CR, Evans JJ, Wilson BA, Martin MGM, Balardin JB, et al. Semantic strategy training increases memory performance and brain activity in patients with prefrontal cortex lesions. Clincal Neurology and Neurosurgery 2013;115(3):309-16.
60. Mitchell AJ, Kemp S, Benito-León J, Reuber M. The influence of cognitive impairment on health-related quality of life in neurological disease. Acta Neuropsychiatrica 2010;22(1):2-13. [DOI: 10.1111/j.1601-5215.2009.00439.x]
61. Monje ML, Vogel H, Masek M, Ligon KL, Fisher PG, Palmer TD. Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Annals of Neurology 2007;62(5):515-20. [DOI: 10.1002/ana.21214]
62. Mora F. Successful brain aging: plasticity, environmental enrichment, and lifestyle. Dialogues in Clinical Neuroscience 2013;15(1):45-52. [PUBMED: PMC3622468]
63. Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB. Incidence of neurologic deficits and rehabilitation of patients with brain tumors. American Journal of Physical Medicine & Rehabilitation 2001;80(5):346-50.
64. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. The Lancet Oncology 2004;5(7):399-408.
65. Palmer SL, Reddick WE, Glass JO, Gajjar A, Goloubeva O, Mulhern RK. Decline in corpus callosum volume among pediatric patients with medulloblastoma: longitudinal MR imaging study. American Journal of Neuroradiology 2002;23(7):1088-94. [PUBMED: 12169462]
66. Peiffer AM, Lyrer CM, Greene-Schloesser D, Kearns WT, Hinson WH, Tattor SB, et al. Normal tissue complication modeling of the brain: dose-volume histogram analyses of neurocognitive outcomes of two CCOP trials. Neuro-Oncology. 2011; Vol. 13:iii73-5. [DOI: 10.1093/neuonc/nor166]
67. Randolph C. Repeatable battery for the assessment of neuropsychological status (RBANS). Psychological Corporation, San Antonio 1998.
68. Reddick WE, Shan ZY, Glass JO, Helton S, Xiong X, Wu S, et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 2006;106(4):941-9. [PUBMED: 16411228]
69. Reitan RM. Trail making test manual for administration and scoring. Reitan Neuropsychology Laboratory, Tucson 1989.
70. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
71. Robinson DM, Keating GM. Memantine: a review of its use in Alzheimer's disease. Drugs 2006;66(11):1515-34. [PUBMED: 16906789]
72. Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. International Journal of Radiation Oncology* Biology* Physics 1980;6(9):1215-28.
73. Smith JV, Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Applied Microbiology and Biotechnology 2004;64(4):465-72. [DOI: 10.1007/s00253-003-1527-9]
74. Steinberg M, Lyketsos CG. Pharmacological therapies in Alzheimer's Disease. In: Abou-Saleh MT, Katona C, Kumar A editor(s). Principles and Practice of Geriatric Psychiatry. 3rd Edition. Oxford: John Wiley & Sons, 2010. [DOI: 10.1002/9780470669600.ch52]
75. Szerlip N, Rutter C, Ram N, Yovino S, Kwok Y, Maggio W, et al. Factors impacting volumetric white matter changes following whole brain radiation therapy. Journal of Neuro-Oncology 2011;103(1):111-9. [PUBMED: 20725847]
76. Tallet A, Dhermain F, Taillia H, Ricard D, Mornex F, Métellus P. Cognition and radiation therapy for brain metastases: a new paradigm to define [Cognition et radiothérapie dans les métastases cérébrales: un nouveau paradigme à définir]. Bulletin du Cancer 2013;100(1):63-9. [DOI: 10.1684/bdc.2012.1682]
77. Taphoorn MJB. Neurocognitive sequelae in the treatment of low-grade gliomas. Seminars in Oncology 2003;30(6):45-8. [PUBMED: 14765385]
78. Taphoorn MJB, Klein M. Cognitive deficits in adult patients with brain tumours. The Lancet Neurology 2004;3(3):159-68.
79. Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J, et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. Journal of Neuro-Oncology 2009;94(1):63-8.
80. van der Maazen RWM, Kleiboer BJ, Verhagen I, van der Kogel AJ. Repair capacity of adult rat glial progenitor cells determined by an in vitro clonogenic assay after in vitro or in vivo fractionated irradiation. International Journal of Radiation Biology 1993;63(5):661-6. [PUBMED: 8099113]
81. Vigliani MC, Sichez N, Poisson M, Delatrre JY. A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. International Journal of Radiation Oncology* Biology* Physics 1996;35(3):527-33.
82. Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ. Mechanism of action of methylphenidate: insights from PET imaging studies. Journal of Attention Disorders 2002;6:S31-43.
83. Wang Y, Pan L, Sheng X, Mao Y, Yao Y, Wany E, et al. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. European Journal of Medical Research 2012;17(1):25. [DOI: 10.1186/2047-783X-17-25]
84. Wechsler. Wechsler Adult Intelligence Scale-Revised. Psychological Corporation, San Antonio 1981.
85. Wefel JS, Vardy J, Ahles T, Schagen SB. International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. The Lancet Oncology 2011;12(7):703-8. [DOI: 10.1016/S1470-2045(10)70294-1]
86. Welzel G, Fleckenstein K, Schaefer J, Hermann B, Kraus-Tiefenbacher U, Mai SK, et al. Memory function before and after whole brain radiotherapy in patients with and without brain metastases. International Journal of Radiation Oncology* Biology* Physics 2008;72(5):1311-8. [DOI: 10.1016/j.ijrobp.2008.03.009]
87. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell 2008;132(4):645-60.
88. Zucchella C, Capone A, Codella V, De Nunzio AM, Vecchione C, Sandrini G, et al. Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial. Journal of Neuro-Oncology 2013;114(1):93-100.